Allison Ross Eckard
Overview
Explore the profile of Allison Ross Eckard including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
516
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lopez C, Moreland A, Amaya S, Bisca E, Mujica C, Wilson T, et al.
JMIR Form Res
. 2025 Jan;
9:e64258.
PMID: 39819749
Background: Individuals with co-occurring posttraumatic stress disorder (PTSD) and HIV are at high-risk for negative HIV-related outcomes, including low adherence to antiretroviral therapy, faster disease progression, more hospitalizations, and almost...
2.
Kolossvary M, Schnittman S, Zanni M, Fitch K, Fichtenbaum C, Aberg J, et al.
JAMA Cardiol
. 2024 Dec;
10(3):254-264.
PMID: 39661372
Importance: In a mechanistic substudy of the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE) randomized clinical trial, pitavastatin reduced noncalcified plaque (NCP) volume, but specific protein and gene...
3.
Dantas M, Eckard A, Taylor M, Morrisette T, Williams D, Thacker S, et al.
Hosp Pediatr
. 2024 Oct;
14(11):909-918.
PMID: 39385677
Objectives: We examined local prescribing patterns across the entire treatment course for children treated for uncomplicated urinary tract infection (UTI) to determine opportunities for antibiotic stewardship initiatives. Methods: We conducted...
4.
Eckard A, Wu Q, Sattar A, Ansari-Gilani K, Labbato D, Foster T, et al.
Lancet Diabetes Endocrinol
. 2024 Jul;
12(8):523-534.
PMID: 38964353
Background: HIV-associated lipohypertrophy, which is characterised by an abnormal accumulation of abdominal visceral adipose tissue, remains problematic in people with HIV. Effective interventions are lacking, despite HIV-associated lipohypertrophy carrying a...
5.
Abidi M, Umbleja T, Overton E, Burdo T, Flynn J, Lu M, et al.
J Acquir Immune Defic Syndr
. 2024 Jan;
95(5):470-478.
PMID: 38180893
Background: Cytomegalovirus (CMV) seropositivity is associated with poor outcomes, including physical function impairment, in people without HIV. We examined associations between CMV IgG titer and physical function in virologically suppressed...
6.
Sanford B, Toll B, Eckard A, Sterba K, Cummings K, Baker N, et al.
Addict Sci Clin Pract
. 2022 Nov;
17(1):61.
PMID: 36335376
Background: With advances in antiretroviral therapy, people with HIV (PWH) are living longer and are less likely to die from AIDS-related complications. Yet, prior research has shown that smoking is...
7.
Foster M, Toll B, Ware E, Eckard A, Sterba K, Rojewski A
Int J Environ Res Public Health
. 2022 Oct;
19(19).
PMID: 36232195
People with HIV (PWH) have higher rates of tobacco use compared to their societal counterparts and are disproportionately affected by tobacco-related morbidity and mortality. A needs assessment was conducted to...
8.
Eckard A, Borow K, Mack E, Burke E, Atz A
Pediatrics
. 2021 Feb;
147(5).
PMID: 33579813
Multisystem inflammatory syndrome in children (MIS-C) is a serious postinfectious immune dysregulation associated with coronavirus disease 2019 that may present with severe and life-threatening cardiovascular dysfunction, hemodynamic instability, shock, and...
9.
Eckard A, Hughes H, Hagood N, ORiordan M, Labbato D, Kosco J, et al.
J Acquir Immune Defic Syndr
. 2020 Oct;
86(2):231-239.
PMID: 33065582
Background: Fecal calprotectin (FC), a biomarker of gastrointestinal (GI) inflammation, is used in the diagnosis and management of inflammatory bowel disease. HIV infection severely damages gut-associated lymphoid and epithelial tissues...
10.
Eckard A, Hughes H, Hagood N, ORiordan M, Labbato D, Kosco J, et al.
J Acquir Immune Defic Syndr
. 2020 Jan;
83(5):e30-e33.
PMID: 31913998
No abstract available.